Journal of Virus Eradication (Jul 2016)
34 Novel conserved element HIV/SIV DNA vaccines maximize breadth and magnitude of immune response
- B.K. Felber,
- X. Hu,
- A. Valentin,
- F. Dayton,
- Y. Cai,
- M. Rosati,
- C. Alicea,
- N.Y. Sardesai,
- R. Gautam,
- M.A. Martin,
- J.I. Mullins,
- G.N. Pavlakis
Affiliations
- B.K. Felber
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- X. Hu
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- A. Valentin
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- F. Dayton
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- Y. Cai
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- M. Rosati
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- C. Alicea
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- N.Y. Sardesai
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, United States
- R. Gautam
- National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States
- M.A. Martin
- National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States
- J.I. Mullins
- University of Washington, Seattle, United States
- G.N. Pavlakis
- National Cancer Institute at Frederick, Center for Cancer Research, Vaccine Branch, Frederick, United States
- Journal volume & issue
-
Vol. 2
p. 20
